Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1981 1
1987 1
1992 1
1994 1
1995 1
1998 1
1999 1
2000 1
2001 1
2003 4
2004 2
2005 4
2006 8
2007 7
2008 9
2009 11
2010 6
2011 13
2012 10
2013 8
2014 13
2015 12
2016 11
2017 16
2018 18
2019 12
2020 19
2021 24
2022 30
2023 26
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
The definition of primary and secondary glioblastoma.
Ohgaki H, Kleihues P. Ohgaki H, et al. Clin Cancer Res. 2013 Feb 15;19(4):764-72. doi: 10.1158/1078-0432.CCR-12-3002. Epub 2012 Dec 3. Clin Cancer Res. 2013. PMID: 23209033 Review.
Glioblastoma is the most frequent and malignant brain tumor. The vast majority of glioblastomas (~90%) develop rapidly de novo in elderly patients, without clinical or histologic evidence of a less malignant precursor lesion (primary glioblastomas). ...Decisi …
Glioblastoma is the most frequent and malignant brain tumor. The vast majority of glioblastomas (~90%) develop rapidly de novo …
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
Verdugo E, Puerto I, Medina MÁ. Verdugo E, et al. Cancer Commun (Lond). 2022 Nov;42(11):1083-1111. doi: 10.1002/cac2.12361. Epub 2022 Sep 21. Cancer Commun (Lond). 2022. PMID: 36129048 Free PMC article. Review.
Glioblastoma multiforme (GBM) is the most aggressive and common malignant primary brain tumor. ...Several molecular parameters have been used to achieve an accurate and personalized characterization of glioblastoma in patients, including epigenetic, genetic, transcr …
Glioblastoma multiforme (GBM) is the most aggressive and common malignant primary brain tumor. ...Several molecular parameters have b …
Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.
Moody TW, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey SA, Jensen RT. Moody TW, et al. Front Endocrinol (Lausanne). 2021 Sep 1;12:728088. doi: 10.3389/fendo.2021.728088. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34539578 Free PMC article. Review.
Activation of GPCR on tumors can have prominent growth effects, and GPCRs are frequently over-/ectopically expressed on tumors and thus can be used for targeted therapy. CNS/neural tumors are receiving increasing attention using this approach. ...We review in this paper ev …
Activation of GPCR on tumors can have prominent growth effects, and GPCRs are frequently over-/ectopically expressed on tumors and thus can …
Engineered cells as glioblastoma therapeutics.
Ramanathan A, Lorimer IAJ. Ramanathan A, et al. Cancer Gene Ther. 2022 Feb;29(2):156-166. doi: 10.1038/s41417-021-00320-w. Epub 2021 Mar 22. Cancer Gene Ther. 2022. PMID: 33753869 Free PMC article. Review.
In addition to small molecule, antibody, and engineered virus approaches, engineered cells are also being explored as glioblastoma therapeutics. This includes CAR-T cells, CAR-NK cells, as well as engineered neural stem cells and mesenchymal stem cells. ...Finally, …
In addition to small molecule, antibody, and engineered virus approaches, engineered cells are also being explored as glioblastoma th …
Potential effects of nicotine on glioblastoma and chemoradiotherapy: a review.
McConnell DD, Carr SB, Litofsky NS. McConnell DD, et al. Expert Rev Neurother. 2019 Jun;19(6):545-555. doi: 10.1080/14737175.2019.1617701. Epub 2019 May 17. Expert Rev Neurother. 2019. PMID: 31092064 Review.
Use of tobacco products following diagnosis and during the period of treatment for non-neural tumors detrimentally affects treatment and prognosis. Approximately, 16-28% of patients with glioblastoma continue to smoke after diagnosis and during treatment. ...English …
Use of tobacco products following diagnosis and during the period of treatment for non-neural tumors detrimentally affects treatment …
Gene Delivery in Neuro-Oncology.
Dixit K, Kumthekar P. Dixit K, et al. Curr Oncol Rep. 2017 Sep 2;19(11):69. doi: 10.1007/s11912-017-0628-z. Curr Oncol Rep. 2017. PMID: 28866732 Review.
PURPOSE OF REVIEW: Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults with a dismal prognosis despite aggressive multimodal management thus novel treatments are urgently needed. ...RECENT FINDINGS: The most commonly studied vectors are …
PURPOSE OF REVIEW: Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults with a dismal prognosis d …
Epileptogenesis and Tumorigenesis in Glioblastoma: Which Relationship?
Rossi J, Cavallieri F, Biagini G, Rizzi R, Russo M, Cozzi S, Giaccherini L, Pisanello A, Valzania F. Rossi J, et al. Medicina (Kaunas). 2022 Sep 26;58(10):1349. doi: 10.3390/medicina58101349. Medicina (Kaunas). 2022. PMID: 36295510 Free PMC article. Review.
Epilepsy is reported in 29-52% of patients with glioblastoma (GBM) and has an important role in the natural history of this tumor and patients' life quality. ...
Epilepsy is reported in 29-52% of patients with glioblastoma (GBM) and has an important role in the natural history of this tumor and …
Metabolic regulation on the immune environment of glioma through gut microbiota.
Lyu Y, Yang H, Chen L. Lyu Y, et al. Semin Cancer Biol. 2022 Nov;86(Pt 2):990-997. doi: 10.1016/j.semcancer.2021.05.005. Epub 2021 May 7. Semin Cancer Biol. 2022. PMID: 33971263 Review.
Glioma comprises 80 percent of malignant brain cancer and glioblastoma (GBM) is the most malignant kind. GBM has a reputation for its suppressive immune environment and poor patient prognosis. ...
Glioma comprises 80 percent of malignant brain cancer and glioblastoma (GBM) is the most malignant kind. GBM has a reputation for its …
Glioblastoma revisited: from neuronal-like invasion to pacemaking.
Heuer S, Winkler F. Heuer S, et al. Trends Cancer. 2023 Nov;9(11):887-896. doi: 10.1016/j.trecan.2023.07.009. Epub 2023 Aug 15. Trends Cancer. 2023. PMID: 37586918 Review.
In recent years, two developments have helped us to better understand the fundamental biology of glioblastoma: the description of a striking intratumoral heterogeneity including gene expression-based cell states, and the discovery that neuro-cancer interactions and cancer- …
In recent years, two developments have helped us to better understand the fundamental biology of glioblastoma: the description of a s …
Targeting Glioblastoma Tumor Microenvironment.
Butler M, Prasad S, Srivastava SK. Butler M, et al. Adv Exp Med Biol. 2020;1296:1-9. doi: 10.1007/978-3-030-59038-3_1. Adv Exp Med Biol. 2020. PMID: 34185283 Review.
Glioblastoma, also referred to as glioblastoma multiforme (GBM), is an aggressive type of brain cancer. The prognosis for GBM is poor with an average medium survival rate of 12-15 months. GBM is highly challenging to treat due to neural stem cells phenotypic …
Glioblastoma, also referred to as glioblastoma multiforme (GBM), is an aggressive type of brain cancer. The prognosis for GBM …
238 results